Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
Abstract Abnormal initiation and control of voluntary movements are among the principal manifestations of Parkinson’s disease (PD). However, the processes underlying these abnormalities and their potential remediation by dopamine treatment remain poorly understood. Normally, movements depend on the...
Guardado en:
Autores principales: | Noham Wolpe, Jiaxiang Zhang, Cristina Nombela, James N. Ingram, Daniel M. Wolpert, Cam-CAN, James B. Rowe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6926e5759234e37898a9275b79364e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
por: Juri C,Carlos, et al.
Publicado: (2006) -
Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
por: Hirofumi Matsuyama, et al.
Publicado: (2021) -
Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
por: Szász JA, et al.
Publicado: (2019) -
La integración sensorial en el desarrollo y aprendizaje infantil /
por: Serrano, Paula
Publicado: (2019) -
Additional baricitinib loading dose improves clinical outcome in COVID-19
por: Hasan Md Jahidul, et al.
Publicado: (2020)